Navigation Links
NuView Life Sciences Announces Presentation of Data for Novel Prostate and Bladder Cancer Molecular Diagnostic at SNMMI
Date:6/18/2013

tion of malignant Breast and Prostate tumors using PET and plans to initiate multi-center clinical trials in 2013.

About NuView Life Sciences

NuView Life Sciences is a privately held company whose mission is the development and commercialization of a new generation of molecular imaging diagnostic agents and disease-specific biomarkers. We are developing a vertically integrated, radiopharmaceutical manufacturing, and distribution organization to address current supply problems in the marketplace and facilitate development of our product pipeline.

For more information, please visit http://www.nuviewinfo.com.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10828830.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. NuView Life Sciences and Thomas Jefferson University Sign Agreement for Exclusive Development and Commercialization Rights to Novel Prostate Cancer Diagnostic
2. Positive Clinical Breast Cancer Data Presented for NuView’s Molecular Imaging Biomarker NLS-VPAC1
3. Pressure BioSciences, Inc. Closes Final Tranche of Series J Above Market Private Placement - Total Amount Raised in PIPE Slightly Exceeds $2 Million Goal
4. Pittsburgh Life Sciences Greenhouse Makes Significant Reductions Due to Uncertain Funding
5. Eagle Biosciences Introduces Highly Sensitive Calprotectin ELISA Assay Kit
6. IntelliCell BioSciences Receives US Patent for its Stem Cell Extraction Technology
7. MEI Pharma Adds Former YM BioSciences CEO Nick Glover To Board Of Directors
8. BioDelivery Sciences Announces NDA Submission for BUNAVAIL on Track Following Positive Pre-NDA Meeting with FDA
9. Caris Life Sciences ASCO Presentation Highlights the Utility of Molecular Profiling for the Management of Rare and Aggressive Cancers
10. Caris Life Sciences Announces Planned Expansion of Next-Generation Sequencing (NGS) Capabilities
11. Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... 2014  ImmunoClin Corporation (IMCL) is a U.S. ... infectious diseases as well as nutraceuticals. The company ... pathologies like cardiovascular disease, Alzheimer,s disease and gastrointestinal ... will complete the strategic relocation of its corporate ... a key center of North American healthcare and ...
(Date:7/29/2014)... ST. LOUIS , July 29, 2014  Sigma-Aldrich ... global water and energy use, increased its investment in ... community service around the world last year, the Company ... Report: What if Science Changed the World? ... has earned several honors for being a responsible corporate ...
(Date:7/29/2014)... The first product launch from start-up Hurley ... robotics. What sets Droidles completely apart from other stand ... them to communicate, share code with each other and ... “The invention is the system,” said Hurley Research founder ... of their own, both physically and on the internet." ...
(Date:7/29/2014)... FL (PRWEB) July 29, 2014 EXpressLO ... situ lift out specimen preparation solutions, has been granted ... Office for specimen manipulation methods incorporating a unique specimen ... This is the second company patent for EXpressLO ... Giannuzzi. , These complementary patents extend EXpressLO’s ...
Breaking Biology Technology:ImmunoClin Corporation (IMCL) Relocates Corporate Headquarters to Washington, DC 2ImmunoClin Corporation (IMCL) Relocates Corporate Headquarters to Washington, DC 3Sigma-Aldrich Achieves Record Success in Environmental, Community Initiatives 2Sigma-Aldrich Achieves Record Success in Environmental, Community Initiatives 3Droidles, the Social Network of Robots and Open Source Platform for the Internet of Things, Launches for Crowd Funding on IndieGoGo.com 2EXpressLO LLC Granted Second U.S. Patent for Innovative Specimen Preparation Methods 2
... CBM ) reports third quarter results for the period ... Reported sales decreased by 14.6%, and excluding the impact ...   Adjusted EBITDA was $8.5 million in the third quarter ... Debt, net of cash was $71.4 million at the end ...
... Life Sciences Holdings, Inc. (OTC Bulletin Board: ... discovery, development and commercialization of novel drugs in the therapeutic ... the Company has been awarded a cash grant under the ... part of the Patient Protection and Affordable Care Act of ...
... (OTC Bulletin Board: CVAT, Berlin & Stuttgart: WTC) proudly announces ... Frankfurt Stock Exchange under the ticket symbol WTC. ... another milestone with the listing on the Frankfurt Stock Exchange ... us gain visibility and support in the European market.  The ...
Cached Biology Technology:Cambrex Reports Third Quarter 2010 Results 2Cambrex Reports Third Quarter 2010 Results 3Cambrex Reports Third Quarter 2010 Results 4Cambrex Reports Third Quarter 2010 Results 5Cambrex Reports Third Quarter 2010 Results 6Cambrex Reports Third Quarter 2010 Results 7Cambrex Reports Third Quarter 2010 Results 8Cambrex Reports Third Quarter 2010 Results 9IRS Awards Cash Grant to Advanced Life Sciences Under the Qualifying Therapeutic Discovery Project 2IRS Awards Cash Grant to Advanced Life Sciences Under the Qualifying Therapeutic Discovery Project 3Listing on Frankfurt Stock Exchange for CTI (http://ctinanotech.com) 2Listing on Frankfurt Stock Exchange for CTI (http://ctinanotech.com) 3
(Date:7/29/2014)... University of Kent has shown for the first time ... breakthrough that could have a major impact on cancer ... Biosciences uncovered the mechanism whereby the physical properties of ... filaments are ,fine-tuned, to undertake different functions. , ... stable, providing a framework for the cell, others are ...
(Date:7/29/2014)... JULY 2014 With thirty days to go and ... FEBS-EMBO 2014 Conference are well underway. The event, a ... (FEBS), EMBO, and the French Society for Biochemistry and ... August to Thursday, 4 September at the Palais des ... is the largest meeting for the life sciences in ...
(Date:7/29/2014)... two of the major disciplines behind Jurassic Park is ... stunning photographs and unique illustrations. , Fossil Insects, by ... incredible preservation and diversity of fossilised insects from around ... fossils can tell us about the ancient and modern ... the mosquito in Jurassic Park, many of the hundreds ...
Breaking Biology News(10 mins):Counting down to FEBS-EMBO 2014 in Paris, France 2Unique images bring fossil insects back to life 2
... Ont., July 12, 2001--Eating nuts every day could help ... to new research from St. Michael,s Hospital and the ... by the journal Diabetes Care , a team ... Toronto Department of Nutritional Sciences; St. Michael,s Hospital Risk ...
... Beach, FL. Research to be presented at the ... of Ingestive Behavior (SSIB), the foremost society for research ... that caffeine added to sugar-sweetened, carbonated beverages teaches adolescents ... amount of caffeine added to an unfamiliar beverage was ...
... Research to be presented at the upcoming annual meeting of ... foremost society for research into all aspects of eating and ... increases our willingness to pay for food, while simultaneously decreasing ... ever wondered about why you are willing to pay more ...
Cached Biology News:A 'nutty' solution to type 2 diabetes management 2
...
... and Tissue Staining Kits are intended for ... of histological and cytological specimens. These kits ... manufactured by either R&D Systems or by ... the formation of the Avidin-Biotin Complex (ABC) ...
... jetSI-ENDO is an easy-to-use siRNA transfection ... out endogenous genes in a variety of ... comes with an optimized, straightforward protocol. High ... are obtained following transfection of 20 to ...
... is a tetramethylrhodamine-conjugated jetSI-ENDO (excitation ... 580 nm), the powerful siRNA ... used to determine the transfection ... delivery and trafficking of siRNAs. ...
Biology Products: